Dublin, Dec. 23, 2016 -- Research and Markets has announced the addition of the "Snapshot of Japanese Pre-Clincal Outsourcing Market 2016" report to their offering.
This report discusses about the preclinical outsourcing market in Japan, specifically focusing on preclinical service providers with animal testing capability for pharmaceutical companies.
The preclinical market peaked in 2008, and started to decline afterward. We estimate the market size in 2015 was almost the same as 2010 or even below.
Most players are dedicated to the preclinical services. While local players such as SNBL and Ina Research still show significant presence in Japan, global firms such as Charles River and Harlan have been showing prominence gradually over the years.
We estimate the market size would remain flat or slightly decrease over the years. While local firms barely hold on in the mean time, we anticipate global firms will take the leading role in the long run, with wider regional reach and service offerings.
Key Topics Covered:
1. Summary
2. Market Overview
3. Industry Association
4. Key Local Players
5. Global Players
6. Future Prospect
Companies Mentioned
- Charles River
- Harlan
- Ina Research
- SNBL
For more information about this report visit http://www.researchandmarkets.com/research/2fmnhx/snapshot_of
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Consulting and Outsourcing


EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
Coca-Cola’s Costa Coffee Sale Faces Uncertainty as Talks With TDR Capital Hit Snag
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing 



